News Focus
News Focus
Replies to #36504 on Biotech Values
icon url

DewDiligence

10/30/06 8:46 AM

#36506 RE: Biowatch #36504

Baraclude beats Hepsera with ease and Tyzeka beats Hepsera with ease. The head-to-head study that would really be interesting is Baraclude vs Tyzeka, but neither NVS/IDIX nor BMY is likely to sponsor such a study.